Ann: New Territory Licensed for Sofpironium Bromide with Kaken, page-20

Whilst this announcement won't mean a lot of hard cash up front for BOT, it's REAL value is in that is another market that SB is being released into. Another country will now be using our product (well, the 5% version not our improved 15% version). This means more promotion, more patients, more success for SB in general. Where BOT will significantly benefit from this and further countries under Kaken's remit, is that it all starts to add up as SB getting a reputation as THE product of choice for hyperhidrosis sufferers.